Comprehensive regulation-by-regulation analysis of FDA CFR Part 211 Subpart E (Control of Components and Drug Product Containers and Closures) with direct links to Form 483 observations and Warning Letters from 2017-2025.
PharmaBenchmark: FDA Subpart E – Components & Containers Intelligence Report
Original price was: $295.00.$240.00Current price is: $240.00.
9999 in stock
9999 in stock
Description
PharmaBenchmark: FDA Subpart E – Components & Containers Intelligence Report
OVERVIEW:
This comprehensive, regulation-by-regulation analysis covers FDA CFR Part 211 Subpart E (Control of Components and Drug Product Containers and Closures) regulations including:
• § 211.80 – General requirements
• § 211.82 – Receipt and storage of untested components, drug product containers, and closures
• § 211.84 – Testing and approval or rejection of components, drug product containers, and closures
• § 211.86 – Use of approved components, drug product containers, and closures
• § 211.87 – Retesting of approved components, drug product containers, and closures
• § 211.89 – Rejected components, drug product containers, and closures
• § 211.94 – Drug product containers and closures
WHAT’S INCLUDED:
Direct links to every Form 483 observation and Warning Letter from 2017 through 2025, organized by specific regulation. Each regulation maps the complete enforcement landscape, showing citation frequency and providing active hyperlinks to all 483s.
WHO SHOULD USE THIS:
Quality, compliance, and regulatory affairs professionals who need:
• Rapid benchmarking capability to assess organizational risk exposure
• Validation of CAPA effectiveness against industry-wide enforcement patterns
• Preparation of inspection-ready responses based on real-world FDA expectations
• Data to benchmark potential partners and competitors
KEY BENEFITS:
• Eliminates exhaustive FDA database searches
• Delivers what typically requires weeks or months of research in a single document
• Provides subpart-level granularity for precise, reliable data
• Transforms enforcement data into strategic competitive advantage
• Saves hundreds of professional hours
Built by life sciences compliance experts, PharmaBenchmark delivers the most cost-effective pathway to real-time FDA Subpart E compliance benchmarking.
